Articles

1. miR-210-5p Promotes Pulmonary Hypertension by Blocking ATP2A2

   • Boxiang Wang
   • Yidin Xu
   • Linbo Yuan

   Original Article 24 April 2024

   

2. Outcomes With Hybrid Catheter-Directed Therapy Compared With Aspiration Thrombectomy for Patients With Intermediate-High Risk Pulmonary Embolism

   • Sylwia Sławek-Szmyt
   • Aleksander Araszkiewicz
   • Maciej Lesiak

   Routine Article 02 April 2024

   

3. Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte?

   • Saifei Liu
   • Indy AJ Lawrie
   • John D. Horowitz

   Invited Editorial 23 March 2024

   

4. Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures

   • Vincenzo Russo
   • Eleonora Caiazza
   • Gerardo Nigro

   Original Article Open access 20 March 2024

   

5. A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms

   • András Nagy
   • Denise Börzsei
   • Renáta Szabó

   Review Article Open access 16 March 2024

   

6. Surgical Treatment for Type A Aortic Dissection after Endovascular Aortic Repair: A 12-year, Single-Center Study

   • Yuan Xue
   • Shipan Wang
   • Haiyang Li

   Original Article 15 March 2024

   

7. Effectiveness of Vasopressin Against Cardiac Arrest: A Systematic Review of Systematic Reviews

   • Jonathan Ka-Ming Ho
   • Hon-Lon Tam
   • Leona Yuen-Ling Leung

   Review Article Open access 12 March 2024

   

8. The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

   • Jun Gu
   • Zhi-Hua Han
   • Jun-feng Zhang

   Original Article 11 March 2024

   

9. Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials

   • Robert S. Rosenson
   • Daniel J. Rader
   • Robert Pordy

   Short Communication Open access 06 March 2024

   

10. Exercise Improves Heart Function after Myocardial Infarction: The Merits of AMPK

    • Xiaodi Zhang
    • Yi Zhao
    • Dengshen Zhang

    Review Article Open access 04 March 2024

    

11. Aloperine Alleviates Myocardial Injury Induced by Myocardial Ischemia and Reperfusion by Activating the ERK1/2/β-catenin Signaling Pathway

    • Shichao Wei
    • Feng Ju
    • Zhaoyang Hu

    Original Article 28 February 2024

    

12. An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity

    • Sa Liu
    • Jiaqin Liu
    • Shengyu Tan

    Original Article 24 February 2024

    

13. Isoimperatorin Inhibits Angiogenesis by Suppressing VEGFR2 Signaling Pathway

    • Yating Xu
    • Di Xia
    • Minglu Liang

    Original Article 16 February 2024

    

14. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids

    • Hani Sabbour
    • Deepak L. Bhatt
    • Ronney Shantouf

    Review Article Open access 16 February 2024

    

15. Safety and Effectiveness of Antidysrhythmic Drugs for Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation: a Systematic Review and Bayesian Network Meta-analysis

    • Ian S. deSouza
    • Pragati Shrestha
    • Henry Thode Jr.

    Review Article 07 February 2024

    

16. Dapagliflozin for Atrial Fibrillation

    • Na Li
    • Mihail G. Chelu
    • Yochai Birnbaum

    Invited Editorial 06 February 2024 Pages: 1 - 3

    

17. The Case Continues to Build: More Data that Intracoronary Thrombolysis Is Safe and Effective in STEMI

    • Spencer Ng
    • Kevin Friede
    • George A. Stouffer

    Editorial 06 February 2024 Pages: 207 - 208

18. Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data

    • Qiuyu Xu
    • Gang Chen
    • Xuemei Li

    Original Article 06 February 2024

    

19. IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area

    • Yanyan Ye
    • Fangyuan Chang
    • Yingchun Xu

    Letter to the Editor 31 January 2024

20. Changes in Heart Rate Variability Parameters Following Radiofrequency Ablation in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis

    • Mahsa Mansourian
    • Zahra Teimouri-jervekani
    • Marjan Mansourian

    Review Article 30 January 2024

    

21. Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem

    • Maurizio Giuseppe Abrignani
    • Edoardo Gronda
    • on behalf of the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Working Groups on Cardiological Chronicity, Cardiorenal, Metabolic, Heart Failure

    Review Article 30 January 2024

    

22. The Function of Circular RNAs in Myocardial Ischemia–Reperfusion Injury: Underlying Mechanisms and Therapeutic Advancement

    • Kai-Yuan Chen
    • Zhou Liu
    • Gui-You Liang

    Review Article 30 January 2024

    

23. Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?

    • Francesco Condello
    • Angelica Cersosimo
    • Paolo Pagnotta

    Editorial 26 January 2024

24. Instent CTO—What Is the Best Treatment Strategy?

    • Mark Sahyouni
    • George A. Stouffer

    Editorial 25 January 2024

25. Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data

    • Zhiqiang Ma
    • Kanling Liu
    • Zhengyi Li

    Review Article Open access 25 January 2024

    

26. The Toll-like Receptor-2/4 Antagonist, Sparstolonin B, and Inflammatory Diseases: A Literature Mining and Network Analysis

    • Rongyuan Yang
    • Qingqing Liu
    • Qing Liu

    Original Article 25 January 2024

    

27. Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study

    • Gary Tse
    • Sharen Lee
    • Jiandong Zhou

    Letter to the Editor 20 January 2024 Pages: 391 - 392

28. Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases

    • Lixiao Hang
    • Ying Zhang
    • Lin Xia

    Review Article 18 January 2024

    

29. Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure

    • Jorge A. Irizarry-Caro
    • Juhee Song
    • Efstratios Koutroumpakis

    Original Article 15 January 2024

    

30. The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing

    • Mohammed Ahmed Akkaif
    • Nur Aizati Athirah Daud
    • Baharudin Ibrahim

    Original Article 15 January 2024

    

31. Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials

    • Daniel A. Gomes
    • João Presume
    • Jorge Ferreira

    Original Article 12 January 2024

    

32. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis

    • Mohamed Nabil Elshafei
    • Muhammad Salem
    • Mohammed Danjuma

    Review Article Open access 02 January 2024

    

33. MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model

    • Nan Wu
    • Caijie Shen
    • Peng Zhong

    Original Article 23 December 2023

    

34. The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin

    • M. V. Basalay
    • James M. Downey
    • D. M. Yellon

    Short Communication Open access 20 December 2023

    

35. Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy

    • Jianning Qin
    • Yao Tan
    • Shunlin Qu

    Review Article 20 December 2023

    

36. When Less is More: Drug-Coated Balloons Threaten a Paradigm Revolution

    • Bilal Alqam
    • James C Blankenship

    Editorial 19 December 2023

37. Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin

    • Evelyn Krohmer
    • Brit Silja Rohr
    • Walter E. Haefeli

    Original Article Open access 19 December 2023

    

38. Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum

    • Andreina Carbone
    • Roberta Bottino
    • Vincenzo Russo

    Original Article 18 December 2023

    

39. ROS-Activated TRPM2 Channel: Calcium Homeostasis in Cardiovascular/renal System and Speculation in Cardiorenal Syndrome

    • Zihan Chen
    • Zaihua Cheng
    • Xiao Huang

    Review Article 18 December 2023

    

40. Establishment and Validation of the Nomogram Model and the Probability of Silent Cerebral Infarction After Ablation Atrial Fibrillation

    • Wei Bao
    • Xiaoqin Hu
    • Chengzong Li

    Original Article 16 December 2023

    

41. Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: the DELIVER Trial

    • Lu Lin
    • Qiu-ping Xiu
    • Yi-feng Chen

    Original Article 14 December 2023

    

42. Use of Antihypertensive Drugs and Arterial Stiffness in the Longitudinal Study of Adult Health (ELSA-Brasil)

    • Isabella Viana Gomes Schettini
    • Sandhi Maria Barreto
    • Roberta Carvalho Figueiredo

    Original Article 12 December 2023

    

43. Colchicine Attenuates Microvascular Obstruction after Myocardial Ischemia-Reperfusion Injury by Inhibiting the Proliferation of Neutrophil in Bone Marrow

    • Ying Tan
    • Xue Bao
    • Biao Xu

    Original Article Open access 08 December 2023

    

44. Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes

    • Arun Samidurai
    • Rakesh C. Kukreja

    Invited Editorial 06 December 2023

    

45. MicroRNA-92a in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area

    • Jin-Zhen Cui
    • Yue-Min Yuan
    • Yan-Yu Lin

    Letter to the Editor 01 December 2023

46. Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies

    • Sarah Cargnin
    • Federica Ferrari
    • Salvatore Terrazzino

    Original Article Open access 01 December 2023

    

47. Comment on “Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients”

    • Shih-Wei Lai

    Letter to the Editor 27 November 2023 Pages: 201 - 202

    

48. Comparison of Efficacy and Safety Between Drug-Coated Balloons Versus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions in Large Vessels: A Study-Level Meta-Analysis of Randomized Control Trials

    • Bing Sun
    • Xu Tong Zhang
    • Rui Rui Chen

    Original Article 24 November 2023

    

49. Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction

    • Cynthia Tannous
    • Rana Ghali
    • Fouad A. Zouein

    Original Article 24 November 2023

    

50. Intervention of Tanshinone IIA on the PGK1-PDHK1 Pathway to Reprogram Macrophage Phenotype After Myocardial Infarction

    • Shan Gao
    • Zhihui Yang
    • Guanwei Fan

    Original Article 22 November 2023